These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6764960)

  • 21. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alpha 1-antitrypsin group system in lung cancer. II].
    Ochmański W
    Folia Med Cracov; 1979; 21(2):333-41. PubMed ID: 317267
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes.
    Kay MA; Graham F; Leland F; Woo SL
    Hepatology; 1995 Mar; 21(3):815-9. PubMed ID: 7875680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of alpha-1-antitrypsin in patients with laryngeal carcinoma].
    Niksić-Ivancić M; Oresković M
    Laryngol Rhinol Otol (Stuttg); 1983 Jun; 62(6):246-8. PubMed ID: 6412008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faecal alpha 1-antitrypsin concentration in the diagnosis and management of patients with pouchitis.
    Boerr LA; Sambuelli AM; Sugai E; Graziano A; Valero J; Kogan Z; Bai J
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):129-33. PubMed ID: 7712304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum alpha 1-antitrypsin in lung cancer].
    Biesiekierska-Chańko I
    Pol Tyg Lek; 1981 Jul; 36(30):1139-41. PubMed ID: 6975927
    [No Abstract]   [Full Text] [Related]  

  • 27. A study of estimation of serum alpha-1-antitrypsin in various forms of leprosy.
    Singhal AL; Parvez M; Chadda VS; Misra SN
    Lepr India; 1981 Jul; 53(3):417-24. PubMed ID: 6974284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiproteolytic activity of serum in patients with chronic pneumonia and lung cancer].
    Bugaĭ BG
    Klin Med (Mosk); 1984 Dec; 62(12):61-3. PubMed ID: 6335206
    [No Abstract]   [Full Text] [Related]  

  • 29. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
    Hashemi M; Naderi M; Rashidi H; Ghavami S
    Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantification of serum alpha-1 antitrypsin as a biological marker in cancer].
    Chimpén Ruiz V; Fonseca Sánchez E; Cruz Hernández JJ; Fermoso García J
    Rev Clin Esp; 1985 Nov; 177(8):419-20. PubMed ID: 3879736
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of smoking and age on serum levels of immune-reactive proteins altered in cancer patients.
    Weiss JF; Wolf GT; Edwards BK; Chretien PB
    Cancer Detect Prev; 1981; 4(1-4):211-7. PubMed ID: 6984657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
    El-Akawi ZJ; Al-Hindawi FK; Bashir NA
    Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of alpha 1-antitrypsin in blood of patients operated on for tumor and benign hyperplasia of the prostate].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):77-8. PubMed ID: 8756736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kallikrein and prekallikrein content and antitryptic activity in the blood serum in serum hepatitis of varying degrees of severity].
    Iakubovskaia RI; Malyshev NA; Farber NA; Didkovskiĭ NA; Paskhina TS
    Vopr Med Khim; 1981; 27(6):804-11. PubMed ID: 6977940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
    Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
    Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
    J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigations of alpha-1-antitrypsin level in blood serum of patients with melanoma of the choroid].
    Matysik A; Jakubowska-Solarska B; Toczołowski J
    Klin Oczna; 1995; 97(9-10):273-5. PubMed ID: 8833947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum alpha-1-antitrypsin in ischemia and rheumatic heart diseases.
    Somayajulu GL; Reddy PP
    Indian J Pathol Microbiol; 1996 Oct; 39(4):271-5. PubMed ID: 9009477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.